Loading market dashboard
Kenvue Inc.
KVUEConsumer DefensiveNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Here are three top-rated consumer dividend stocks that have yields above 3% and have made their way onto the coveted Zacks Rank #1 (Strong Buy) list.
Diamondback Energy's shares rose as the sharp rise in oil prices drove a broad rally across US-based oil producers. Consumer finance company Capital One underperformed during the quarter following its announced acquisition of Brex, an AI-native commercial fintech platform. We added global consumer staples leader Kimberly-Clark to the portfolio following its announced acquisition of Kenvue and subsequent share price decline.
GECC, KVUE and TNET made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 26, 2026.
Investors with an interest in Consumer Products - Staples stocks have likely encountered both Kenvue (KVUE) and L'Oreal SA (LRLCY). But which of these two stocks is more attractive to value investors?
Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy' rating and $120 price objective from Bank of America analysts, who believe that the company's acquisition of Kenvue assets could create long-term value despite near-term integration challenges. The analysts said the deal appears opportunistic, noting the acquisition multiple of about 14 times Kenvue's last-twelve-month adjusted EBITDA and a purchase price of $21.01 per share, roughly in line with Kenvue's market value before Tylenol-related headlines weighed on the stock in September 2025.
TNET, LSCC, STRL, CIVB and KVUE have been added to the Zacks Rank #1 (Strong Buy) List on May 11th, 2026.
KVUE, BP and CIVB made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 11th, 2026.
Kenvue (KVUE) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.24 per share a year ago.
Stock futures are treading water this morning as investors await the latest news on a potential peace deal with Iran and digest a slew of earnings reports; oil prices are falling again this morning amid optimism that the Strait of Hormuz could reopen soon; Arm Holdings shares are falling after the company cited a lack of supply and declining smartphone demand in its latest earnings report; shares of McDonald's and Shell are gaining ground after their earnings topped Wall Street estimates; and DoorDash shares are soaring after the food delivery platform reported solid results and issued a rosy outlook for orders. Here's what you need to know today.
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
Hershey is shifting from cost pressure to earnings expansion amid collapsing cocoa prices, aiding growth recovery and the dividend. General Mills offers an unusually high 7% yield because of temporary headwinds, while restructuring and its pet food segment provide a path back to stability.
Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its skin health and beauty brands.
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal first quarter ended March 29, 2026. “Our year is off to an encouraging start, as our continued efforts to strengthen the business and sharpen execution resulted in delivering net and organic sales growth for the second consecutive quarter, along with meaningful year-over-year improvement in gross margin, operating margin, and EPS,” said Kirk Perry, Chief Executive Officer. “We remain confide.
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on May 27, 2026, to shareholders of record as of the close of business on May 13, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Li.
Consumer staples are boring and reliable. And they typically pay generous dividends.
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2026 financial results before the market opens on May 7, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company's website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century.
I am upgrading Kimberly-Clark shares to a buy ahead of the planned Kenvue merger. The Kenvue deal offers significant cost synergies, enhanced bargaining power, and will position the entity as one of the industry's largest players. The company has raised its dividend for 53 consecutive years and shares currently yield more than 5%.
After its product lineup faced a long-lasting headwind, beverage outfit PepsiCo may finally be back on track. Johnson & Johnson spinoff Kenvue is built for reliable recurring income.
Kenvue Inc. (NYSE: KVUE - Get Free Report) has been assigned an average rating of "Hold" from the sixteen research firms that are presently covering the stock, MarketBeat.com reports. Thirteen investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among
Kimberly-Clark's lean new regional structure is built for speed as it prepares to integrate Kenvue in a $48.7B deal closing in H2 2026.
The combined company, which will include consumer brands such as Kleenex tissues and Huggies diapers as well as over-the-counter products including Tylenol and Listerine, will operate under four geographic business segments.
Kimberly-Clark on Wednesday said its chief financial officer, Nelson Urdaneta, will become the finance chief of the combined company it will create after completing its $40-billion acquisition of Tylenol-maker Kenvue.
DALLAS, April 15, 2026 /PRNewswire/ -- Kimberly‑Clark Corporation (NASDAQ: KMB) today announced the organizational structure and key leadership that will become effective upon completion of its pending acquisition of Kenvue Inc. (NYSE: KVUE). The organizational structure, roles, and responsibilities reflect the fast-and-lean, balanced matrix approach that has built strong operating momentum at Kimberly-Clark since implementing its Powering Care strategy two years ago.
The use of Tylenol by women during pregnancy was not associated with autism in their children, according to results of a nationwide study in Denmark published on Monday.
Consumer staples lagged in 2025 and into this year, creating rare entry points for long-term income investors. Dividend durability remains strong in these four tickers despite short-term earnings pressure across major brands.
Alpha Omega Wealth Management LLC decreased its position in Kenvue Inc. (NYSE: KVUE) by 53.9% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 142,619 shares of the company's stock after selling 167,069 shares during the quarter. Alpha Omega Wealth Management
Capricorn Fund Managers Ltd bought a new position in Kenvue Inc. (NYSE: KVUE) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 282,485 shares of the company's stock, valued at approximately $4,873,000. A number of other hedge funds
Tokyo Lifestyle (NASDAQ: TKLF - Get Free Report) and Kenvue (NYSE: KVUE - Get Free Report) are both consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Dividends Tokyo Lifestyle pays an annual dividend of
Kenvue (KVUE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Synergy CHC (NASDAQ: SNYR - Get Free Report) and Kenvue (NYSE: KVUE - Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Institutional and Insider Ownership 97.6% of Kenvue shares
Shares of Kenvue Inc. (NYSE: KVUE - Get Free Report) have been assigned a consensus recommendation of "Hold" from the sixteen brokerages that are currently covering the firm, MarketBeat.com reports. Thirteen analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month price target among
Stocks are higher this afternoon, as investors brush off the latest U.S.-Iran war developments
Medtronic and Kimberly-Clark are Dividend Aristocrats trading well below historical valuations, offering compelling buy-the-dip opportunities. MDT has strong revenue growth, a robust innovation pipeline, and a 3.3% yield, with a forward P/E of 15.4 versus its historical 17.5. KMB is executing on transformation and innovation, with margin gains, a 5.2% yield, and a forward P/E of 13.0, far below its historical 17.7.
Kimberly-Clark Corporation is undergoing major transformation with a JV in Brazil and the $49B Kenvue acquisition. KMB's shift toward premium brands via KVUE increases revenue scale but introduces integration and brand loyalty risks amid consumer trade-down trends. Post-acquisition, leverage will rise to ~2.8x net debt/EBITDA, pausing share buybacks and potentially impacting credit ratings and dividend stability if synergies disappoint.
First Trust Advisors LP raised its stake in shares of Kenvue Inc. (NYSE: KVUE) by 200.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,667,217 shares of the company's stock after buying an additional 1,778,475 shares
CI Investments Inc. decreased its holdings in shares of Kenvue Inc. (NYSE: KVUE) by 98.2% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,485 shares of the company's stock after selling 519,412 shares during the period. CI
Barington Companies Management LLC acquired a new position in shares of Kenvue Inc. (NYSE: KVUE) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 50,000 shares of the company's stock, valued at approximately $812,000. Kenvue makes up about
Tylenol use among pregnant women fell after U.S. President Donald Trump linked autism to the over-the-counter pain relief medicine, according to an analysis of U.S. emergency room prescribing patterns published in the UK medical journal Lancet.
